Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: complexing capacity

December 30, 2022 Non-pharma applications / Pharma applications

Special Issue “Cyclodextrins: Properties and Applications”

Cyclodextrins (CDs) continue to attract the attention of a large group of researchers, interested mainly in their properties as complexing

Continue reading

Recent Posts

  • New Hungarian Medicine on the Horizon?
  • Rafael Holdings Announced Submission of New Drug Application to FDA for Trappsol®Cyclo™ (remibetadex) for the Treatment of Niemann-Pick Disease Type C
  • New book on cyclodextrin glucanotransferase
  • Cyclodextrin-Branched Polymer Releasing Nitric Oxide with Fluorescent Self-Reporting and Its Combination with Doxorubicin
  • Innovative Titanium Coatings for Enhanced Dental Implants

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (28)
  • Analysis (75)
  • CD as API (360)
  • CD derivatives (442)
  • Cosmetics and toilettry (55)
  • Diagnosis (15)
  • Drug delivery (828)
  • E-ducation (64)
  • Environmental (144)
  • Events (242)
  • Food (239)
  • Gene delivery (22)
  • Household products (6)
  • In Hungarian (4)
  • Life sciences (46)
  • Non-pharma applications (428)
  • Other industrial use (114)
  • Pharma applications (1,237)
  • Supramolecular systems (45)
  • Uncategorized (174)

Top Posts

  • Rafael Holdings Announced Submission of New Drug Application to FDA for Trappsol®Cyclo™ (remibetadex) for the Treatment of Niemann-Pick Disease Type C
  • New Hungarian Medicine on the Horizon?
  • 16th Central European Symposium on Pharmaceutical Technology (CESPT 2027)
  • Mallinckrodt gave up further development of adrabetadex (VTS-270; HPBCD)
  • Health Canada’s Proposal to Enable the Use of alpha-Cyclodextrin as an Emulsifying, Stabilizing or Thickening Agent in Various Foods
  • HPαCD Therapy: A Breakthrough for Krabbe Disease Treatment
  • The monograph of SBECD is official in the European Pharmacopeia
  • A cyclodextrin polymer that could change the future of batteries
  • Cyclodextrin-Branched Polymer Releasing Nitric Oxide with Fluorescent Self-Reporting and Its Combination with Doxorubicin
  • Phosphorylated Beta-cyclodextrin as a New Bone-Targeting Drug Delivery System Could Change the Treatment of Osteoporosis and Other Bone Diseases

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,470 other subscribers
Loading Comments...